The racing industry will come together sometime this summer to ponder eliminating race-day medication, including common anti-bleeder drugs.
The board of the Racing Medication & Testing Consortium announced Wednesday that it will join the National Thoroughbred Racing Association and the American Association of Equine Practitioners for an international summit, with the date to be set shortly.
The move follows weeks of snowballing sentiment on the issue, with various industry groups weighing in both for and against a proposed five-year phase-out of all race-day medication.
On Wednesday, the Keeneland board adopted a resolution supporting “measures to work with other Thoroughbred organizations to adopt a pragmatic approach for the phasing in of uniform medication rules, testing rules and penalties that will result in Thoroughbred racing being conducted in a medication-free environment, both nationally and internationally.” Read more:
Discover more from Ebarrelracing.com
Subscribe to get the latest posts sent to your email.
